key: cord-0890261-0r19yord authors: Magri, Francesca; Giordano, Stefania; Latini, Alessandra; Muscianese, Marta title: New‐onset cutaneous kaposi’s sarcoma following SARS‐CoV‐2 infection date: 2021-11-03 journal: J Cosmet Dermatol DOI: 10.1111/jocd.14549 sha: 1e8b3a760532d5bb292bcbf1502d83ee35737a39 doc_id: 890261 cord_uid: 0r19yord BACKGROUND: COVID‐19 is associated with several cutaneous manifestations, including chilbain‐like lesions, urticaria, erythema multiforme, and maculopapular lesions. Dermatoses may be directly linked to the viral infection or also represent a consequence of systemic therapies administrated for COVID‐19. A potential role of SARS‐CoV‐2 in triggering the reactivation of other viruses, such as HHV‐6, HHV‐7 and Epstein‐Barr virus has been hypothesized. OBJECTIVE: To better understand and hypothesize possible pathogenetic correlations of COVID‐19 with other dermatological conditions. METHODS: We report the case of an 83‐year‐old woman hospitalized in a nursing home for several years. On November 2020, the patient had been diagnosed with SARS‐CoV‐2 infection, with repeated positive swabs until January 2021. After a month, new‐onset asymptomatic cutaneous purplish macular lesions and violaceous patches occurred bilaterally on the feet. RESULTS: An incisional cutaneous biopsy and the histological examination of the plantar lesion revealed the diagnosis of Kaposi Sarcoma. CONCLUSION: We report a unique case of new‐onset bilateral Kaposi's sarcoma following COVID‐19, speculating on a possible role of SARS‐CoV‐2 in the reactivation of human herpes virus‐8 (HHV‐8) infection. This case regards an 83-year-old Caucasian female patient from Southern Italy, hospitalized in a nursing home for several years, and affected by arterial hypertension, cognitive impairment, and bipolar disorder. Her long-term therapy included memantine, clozapine, nimodipine, amlodipine, clopidogrel, cholecalciferol, levothyroxine, atenolol, and pantoprazole. On November 26, 2020, the patient had been diagnosed with SARS-CoV-2 infection, following positive naso-oropharyngeal swab test. The patient had fever (37.5-38.5°) and weakness and after few days interstitial pneumonia occurred. Oxygen saturation ranged between 91% and 96% and diffuse "harsh" breath sounds with no abnormal lung sounds were present. Oxygen therapy was prescribed for one month (maximum FiO2 administrated 40%). In addition, the patient was treated with subcutaneous heparin injections, systemic antibiotics, and systemic steroids. The steroid treatment was initiated with dexamethasone 8 mg/day. After 10 days, the dose was gradually reduced, but the inflammatory response started again, so the dose was increased again to 8 mg/day. After one week, we tried again to slowly reduce the dose halving the dose of dexamethasone and then switching to the oral assumption of methylprednisolone 16 mg. The latter was followed by methylprednisolone 4 mg, and then, we progressively reduced the dose, until the interruption after 6 weeks. Totally, the patient assumed systemic steroids for 8 weeks. On January 5, 2021, the naso-oropharyngeal swab test was repeated with negative result. At the end of January 2021, new-onset asymptomatic cutaneous lesions occurred bilaterally on the feet and a dermatology consultation was scheduled. As reported by the patient's family physician, roundish red spots firstly appeared on the plant and ventral part of the fingers. A large violaceous patch appeared after a few days. On physical examination, multiple purplish tender macular lesions were present bilaterally on the plantar regions and a single purplish patch with irregular borders was located in the central part of the plantar areas, with few nodules at the periphery of the patch. Multiple isolated red spots were diffusely present in the whole plantar region, including the posterior region of fingers ( Figure 1 ). Dermoscopy showed a reddish-violaceous diffuse homogenous pattern ( Figure 2 ). An incisional biopsy was performed on a purplish The patient is currently on clinical follow-up. We report a unique case of KS following SARS-CoV-2 infection. Only In conclusion, we reported this case to add new knowledge concerning possible cutaneous conditions associated with SARS-CoV-2 and COVID-19 therapies, suggesting possible pathogenic explanations of the onset of KS in our case and highlighting some challenging differential diagnoses. Dermoscopy showed a reddish-violaceous diffuse homogenous pattern. The patient has given consent for publication of patient information and images [Color figure can be viewed at wileyonlinelibrary.com] New onset of alopecia areata in a patient with SARS-COV-2 infection: possible pathogenetic correlations? SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features? The clinics of HHV-6 infection in COVID-19 pandemic: pityriasis rosea and kawasaki disease COVID-19 and HHV8 first spotted together: an affair under electron microscopy Herpesviruslike DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies SARS-CoV-2 as possible inducer of viral reactivations Reactivation and lytic replication of kaposi's sarcoma-associated herpesvirus: an update Generalized immunosuppressionassociated type Kaposi's sarcoma in a patient with severe refractory bullous pemphigoid Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta Hydrocortisone activation of human herpesvirus 8 viral DNA replication and gene expression in vitro Kaposi's sarcoma in two patients following low-dose corticosteroid treatment for rheumatological disease SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus An unusual case of pyogenic granuloma-like Kaposi sarcoma The management of pseudomyogenic hemangioendothelioma of the foot: a case report and review of the literature Classic Kaposi sarcoma mimicking chilblains New-onset cutaneous kaposi's sarcoma following SARS-CoV-2 infection None. The authors confirm that the ethical policies of the journal, as noted on the journal's author guidelines page, have been adhered to. The data that support the findings of this study are available from the corresponding author upon reasonable request https://orcid.org/0000-0002-6365-7291